Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.50 |
| ▸ | MPO | P05164 | 4/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5538659 | 0.88 | MPO (0.50) | TAAR1HSPA5MPOCYP2D6TSHR | |
| SCHEMBL5539445 | 0.86 | MPO (0.49) | TAAR1HSPA5MPOCYP2D6TSHR | |
| SCHEMBL10863239 | 0.84 | MGLL (0.51) | TAAR1HSPA5MPOSLC6A4CA12 | |
| SCHEMBL10719846 | 0.84 | MGLL (0.51) | TAAR1HSPA5MPOSLC6A4CA12 | |
| SCHEMBL11373976 | 0.84 | MGLL (0.51) | TAAR1HSPA5MPOSLC6A4CA12 | |
| SCHEMBL647126 | 0.84 | MGLL (0.51) | TAAR1HSPA5MPOSLC6A4CA12 | |
| Ammonia Solution, Strong SCHEMBL29482611 | 0.83 | MGLL (0.50) | TAAR1HSPA5MPOSLC6A4CA12 | |
| SCHEMBL7770815 | 0.83 | CYP4F2 (0.41) | TAAR1TSHRACHE | |
| SCHEMBL9208943 | 0.79 | TAAR1 (0.50) | TAAR1HSPA5MPOIDO1CYP2D6 | |
| SCHEMBL9110833 | 0.79 | TAAR1 (0.55) | TAAR1HSPA5MPOIDO1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160172188-A1 | RINSE SOLUTION FOR SILICA THIN FILM, METHOD OF PRODUCING SILICA THIN FILM, AND SILICA THIN FILM | SAMSUNG SDI CO., LTD. (KR) | 2016-06-16 | — | — | US | claimed |
| US-4228266-A | FROM CYCLOPENTADIENE, DICYCLOPENTADIENE, ALKYL-SUBSTITUTED COMPOUNDS THEREOF AND A HYDROXYSTYRENE DERIVATIVE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-10-14 | — | — | US | claimed |
| US-4138411-A | RUTHENIUM OR OSMIUM CATALYST | RHONE-POULENC S. A. (FR) | 1979-02-06 | — | — | US | claimed |
| US-4129557-A | CYCLOPENTADIENE, DICYCLOPENTADIENE, HYDROXYSTYRENE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1978-12-12 | — | — | US | claimed |
| CN-120092059-A | Heat-resistant adhesive film | 富士复写案株式会社 | 2025-06-03 | — | — | CN | disclosed |
| CN-118525360-A | Heat-resistant adhesive film | 富士复写案株式会社 | 2024-08-20 | — | — | CN | disclosed |
| WO-2024117021-A1 | HEAT RESISTANT ADHESIVE FILM | フジコピアン株式会社 | 2024-06-06 | — | — | WO | disclosed |
| US-11873356-B2 | Curable composition and cured product thereof | DIC CORPORATION (JP) | 2024-01-16 | — | — | US | disclosed |
| WO-2023204091-A1 | HEAT-RESISTANT ADHESIVE FILM | フジコピアン株式会社 | 2023-10-26 | — | — | WO | disclosed |
| CN-111918890-B | Curable composition and cured product thereof | DIC株式会社 | 2023-07-07 | — | — | CN | disclosed |
| CN-111971323-B | Curable composition and cured product thereof | DIC株式会社 | 2023-04-21 | — | — | CN | disclosed |
| US-20230117370-A1 | REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS | OREGON STATE UNIVERSITY (US) | 2023-04-20 | — | — | US | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
| CN-1493600-A | Preparation method and application of modified double maleimide resin | 梁国正 | 2004-05-05 | — | — | CN | disclosed |
| US-4720533-A | Polyorganophosphazene curable in atmosphere | ETHYL CORPORATION (US) | 1988-01-19 | — | — | US | disclosed |
| US-4598160-A | Intermediate phenolic compounds for the catalytic synthesis of chromans | HOFFMANN-LA ROCHE INC. (US) | 1986-07-01 | — | — | US | disclosed |
| EP-0132651-A2 | Use of cyclic phenol organosilane ester | HÜLS AKTIENGESELLSCHAFT (DE) | 1985-02-13 | — | — | EP | disclosed |
| US-4228266-A | FROM CYCLOPENTADIENE, DICYCLOPENTADIENE, ALKYL-SUBSTITUTED COMPOUNDS THEREOF AND A HYDROXYSTYRENE DERIVATIVE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-10-14 | — | — | US | disclosed |
| US-4138411-A | RUTHENIUM OR OSMIUM CATALYST | RHONE-POULENC S. A. (FR) | 1979-02-06 | — | — | US | disclosed |
| US-4129557-A | CYCLOPENTADIENE, DICYCLOPENTADIENE, HYDROXYSTYRENE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1978-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230117370-A1 | REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS | CYP2B6, TYR, CYP2D6 | TAAR1 1986/4885HSPA5 1721/4885MPO 289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.